glp 1 average weight loss per week GLP-1 Agonists Drugs Market Report, 2025-2030 Weight Loss Injections — MesoHealth

doi: 10.1056/NEJMp1001578

In defective drug litigation, the primary party held responsible is typically the drug manufacturer

H., Finan, B., & Tena-Sempere, M

Risks: gastrointestinal (GI) side effects, dehydration (which may contribute to kidney injury and orthostatic hypotension), sarcopenia , and osteoporosis

Key end points included: hospitalisation, heart failure (ICD-10-CM-I50), myocardial infarction (ICD-10-CM-I21), stroke and transient ischaemic attack (ICD-10-CM-I63, G45), development of diabetic microvascular complications (ICD-10-CM-E10.210.4) and all-cause mortality analysed 3 months to 5 years post drug initiation